Axsome Therapeutics (STU:19X) Other Operating Expense : €5.9 Mil (TTM As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Axsome Therapeutics Other Operating Expense?

Axsome Therapeutics's Other Operating Expense for the three months ended in Sep. 2024 was €1.4 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was €5.9 Mil.

Axsome Therapeutics's quarterly Other Operating Expense increased from Mar. 2024 (€1.5 Mil) to Jun. 2024 (€1.5 Mil) but then declined from Jun. 2024 (€1.5 Mil) to Sep. 2024 (€1.4 Mil).

Axsome Therapeutics's annual Other Operating Expense increased from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€3.9 Mil) and increased from Dec. 2022 (€3.9 Mil) to Dec. 2023 (€5.8 Mil).

Axsome Therapeutics Other Operating Expense Historical Data

The historical data trend for Axsome Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axsome Therapeutics Other Operating Expense Chart

Axsome Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

-0.12

-0.04

3.91

5.85

Axsome Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Operating Expense	Get a 7-Day Free Trial															1.51	1.47	1.46	1.48	1.45

Axsome Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.9 Mil.

Axsome Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Axsome Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Axsome Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Axsome Therapeutics Inc (STU:19X) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

AXSM:USA 0HKF:UK

Address

One World Trade Center, 22nd Floor, New York, NY, USA, 10007

Website

https://www.axsome.com

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Axsome Therapeutics Headlines

No Headlines